One-way ANOVA for leucocyte subsets and treatment. (DOCX 17Â kb

Christian Dejaco (12618)

Hans Brezinschek (3459302)

Kerstin Brickmann (3135222)

Martin Stradner (3459305)

Winfried Graninger (3459299)

FigShare

Additional file 1: Table S1. of A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

ROC curves of LC and CD4+lymphocyte counts. Sensitivity for EULAR response blotted against false negative rate (1-specificity), at various threshold settings for baseline LC and CD45+CD3+CD4+ counts. The increasing area under the curve (AUC) corresponds to higher diagnostic accuracy. (TIFF 42Â kb

Additional file 2: Figure S1. of A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

https://figshare.com/articles/Additional_file_1_Table_S1_of_A_combination_of_cellular_biomarkers_predicts_failure_to_respond_to_rituximab_in_rheumatoid_arthritis_a_24-week_observational_study/4361786

Additional file 1: Table S1. of A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

Abstract

Similar works

Full text

Available Versions

FigShare

FigShare